Extract from the Register of European Patents

EP About this file: EP4271402

EP4271402 - COMPOSITION OF BL-8040 [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  06.10.2023
Database last updated on 07.03.2026
FormerThe international publication has been made
Status updated on  09.07.2022
Most recent event   Tooltip30.12.2025New entry: Renewal fee paid 
Applicant(s)For all designated states
BioLineRx Ltd.
2 HaMaayan Street
7177871 Modiin / IL
For all designated states
Biokine Therapeutics Ltd.
Building 13a
Einstein Street, Science Park
Kiryat Weizmann
7403617 Nes Ziona / IL
[2023/45]
Inventor(s)01 / HALBFINGER, Efrat
4322705 RaAnana / IL
02 / PELED, Amnon
6777634 Tel-Aviv / IL
03 / SORANI, Ella
6092000 Kadima / IL
 [2023/45]
Representative(s)Puchberger & Partner Patentanwälte
Reichsratsstraße 13
1010 Wien / AT
[2023/45]
Application number, filing date21914871.529.12.2021
[2023/45]
WO2021IL51548
Priority number, dateUS202063131871P30.12.2020         Original published format: US 202063131871 P
[2023/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022144885
Date:07.07.2022
Language:EN
[2022/27]
Type: A1 Application with search report 
No.:EP4271402
Date:08.11.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 07.07.2022 takes the place of the publication of the European patent application.
[2023/45]
Search report(s)International search report - published on:IL07.07.2022
(Supplementary) European search report - dispatched on:EP13.11.2024
ClassificationIPC:C07K7/08, A61K38/10, A61P35/00, A61K38/02, A61K38/03, C07K7/00
[2024/50]
CPC:
A61P35/00 (EP,IL,KR,US); C07K7/08 (EP,IL,KR); A61K38/12 (US);
A61K38/00 (EP,IL,KR)
Former IPC [2023/45]A61K38/10, A61P35/00, A61K38/02, A61K38/03, C07K7/00, C07K7/64
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/45]
TitleGerman:ZUSAMMENSETZUNG VON BL-8040[2023/45]
English:COMPOSITION OF BL-8040[2023/45]
French:COMPOSITION DE BL-8040[2023/45]
Entry into regional phase27.07.2023National basic fee paid 
27.07.2023Search fee paid 
27.07.2023Designation fee(s) paid 
27.07.2023Examination fee paid 
Examination procedure27.07.2023Examination requested  [2023/45]
02.06.2025Amendment by applicant (claims and/or description)
02.06.2025Date on which the examining division has become responsible
Fees paidRenewal fee
28.12.2023Renewal fee patent year 03
27.12.2024Renewal fee patent year 04
29.12.2025Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XDI] EP1541585  (FUJII NOBUTAKA et al.) [XD] 1-15 * the whole document * * page 34; example 54 *[I] 1-15
 [XI] WO2012095849  (BIOKINE THERAPEUTICS LTD et al.) [X] 1-15 * the whole document * * page 30 - page 31 *[I] 1-15
 [A]   ABRAHAM MICHAL ET AL: "Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-Benzoyl-TN14003", STEM CELLS, WILEY, vol. 25, no. 9, 1 September 2007 (2007-09-01), pages 2158 - 2166, XP002629045, ISSN: 1066-5099, [retrieved on 20070524], DOI: 10.1634/STEMCELLS.2007-0161 [A] 1-15 * the whole document * * page 2160; figure 1 *

DOI:   http://dx.doi.org/10.1634/stemcells.2007-0161
International search[Y] US2013303460  (PELED AMNON et al.) [Y] 1-50 * page 2 para 25; abstract; page 1 para 15; page 2 para 28 - page 3 para 42 *
 [Y] US8017585  (FUJII NOBUTAKA et al.) [Y] 1-50 * page 55 example 54; page 55 lane 50; pages 59, 60 examples 1, 3; pages 63, 64 examples 9, 10 *
 [Y]   ABRAHAM, MICHAL ET AL.: "Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F?benzoyl? TN 14003", STEM CELLS, vol. 25, no. 9, 2007, pages 2158 - 2166, XP002629045, DOI: 10.1634/stemcells.2007-0161 [Y] 1-50 * .# ABRAHAM, Michal, et al. (2007/05/24) page 2160 fig. 1B and para 1; page 48 table 1 *

DOI:   http://dx.doi.org/10.1634/stemcells.2007-0161
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.